Breathe Right International Sales Key To CNS’ $180 Mil. Revenue Target
This article was originally published in The Tan Sheet
CNS is aiming to more than double its revenue in the next five to seven years through extensions of its Breathe Right nasal strip brand in the U.S. and aggressive international expansion
You may also be interested in...
CNS' two new children's Breathe Right nasal strips, now reaching food, drug and mass outlets nationwide, offer a new solution for the "winter woes of a stuffy nose," according to the company.
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands